Posted on

Inbiotec Amber: hyaluronic with succinic acid, the new injectable by IT Pharma

Inbiotec Amber: hyaluronic with succinic acid, the new injectable by IT Pharma

Next Friday, at the 34th National Congress of SEME, IT Pharma is to present Inbiotec Amber, with a paper by Dr. José Luis Latorre

Next Friday, at the 34th National Congress of SEME, IT Pharma is to present Inbiotec Amber, with a paper by Dr. José Luis Latorre

Inbiotec Medical Devices, the new line of healthcare products developed by the IT Pharma group, is bringing its first product to market: Inbiotec Amber, a new injectable comprising 1.1% hyaluronic acid and 1.6% succinic acid. In a paper entitled: A new concept in mesotherapy: Discover the benefits of succinic acid, Doctor Latorre will explain the benefits of this active ingredient sourced from amber.

With this new line of healthcare products for aestheticians and dermatologists, IT Pharma aims to provide professionals with a safe, innovative product that stands out due to its combination of top quality ingredients.

The presentation is set to take place on Friday 22nd in Malaga, Conference Room 1 and will count on the presence of Dr. Pilar Garcia-Las Heras as moderator.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

IT Pharma attends the SEME congress

IT Pharma attends the SEME congress

IT Pharma attended the SEME 2018 to present its latest news, among which were Prostrolane Inner B and Turtlepin

Over 2,000 medical experts attended the Spanish aesthetic medicine congress.

CYet another year running, IT Pharma attended the Spanish Aesthetic Medicine Congress, which took place from 22nd to 24th February in Malaga, organised by the Spanish Society of Aesthetic Medicine (SEME). Scientists specialising in aesthetic medicine attended the three-day Congress Fair, which offered speeches, presentations and stands with representatives from Spain’s main brands.

One of the most eagerly-awaited exhibitions was that of Prostrolane Inner B, a product imported by IT Pharma and commercialised by TOV Medical in Spain. The speech was given by Doctor Juan Miguel Pérez Díaz, from the Pérez Díaz Clinic in Alicante. Over a hundred people attended the presentation about one of the most talked about products in the congress.

The Navarran brand also revealed the new Turtlepin medical device, a head that enables the product or solution to be introduced via hollow hypodermic needles.

This congress is a national and international benchmark, which unites over 2,000 participants each year. According to figures released by the organising company, the number of congress members rose by 10% compared to the previous year, demonstrating the healthy outlook of the sector.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment